SNTI - Senti Biosciences, Inc.
IEX Last Trade
4.06
0.020 0.493%
Share volume: 462
Last Updated: Thu 26 Dec 2024 05:57:42 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.04
0.02
0.50%
Fundamental analysis
13%
Profitability
0%
Dept financing
11%
Liquidity
75%
Performance
10%
Performance
5 Days
4.25%
1 Month
97.63%
3 Months
82.89%
6 Months
1,245.16%
1 Year
660.26%
2 Year
211.19%
Key data
Stock price
$4.06
DAY RANGE
$4.00 - $4.14
52 WEEK RANGE
$0.24 - $16.94
52 WEEK CHANGE
$605.58
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Timothy K. Lu
Region: US
Website: sentibio.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: sentibio.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Dynamics Special Purpose Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination. The company was incorporated in 2021 and is based in Redwood City, California.
Recent news